michigan glp-1 constipation law firm GLP-1s are great, but researchers are busy looking to add options for patients. A new U-M study reveals a missing step in a weight control pathway that could be targeted for obesity Relesium GLP-1 Digestive Support

This article aims to provide an overview of GLP-1 based drugs, focusing on semaglutide (marketed as Ozempic for type 2 diabetes and as Wegovy for obesity) and tirzepatide (marketed as Mounjaro), which is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 agonist

However, clinical trials have only evaluated both drugs within therapeutic dose ranges

Mounjaro is a 'name-brand' form of tirzepatide, a type of medication called a glucagon-like peptide 1 receptor agonist, better known as a GLP-1. Its active ingredient, tirzepatide works by mimicking the GLP-1 hormones that are naturally secreted by the intestine after a meal

I had never blamed her for her weight, but I hadnt understood, either

Some patients benefit from prescription medications, including GLP-1 treatments, while others may succeed with a structured plan focused on nutrition, activity, and lifestyle changes

These are possible effects of quitting tirzepatide medications: Changes in your food preferences Digestive issues, such as diarrhea and nausea Increased appetite Insulin spikes Mood changes Regaining weight Be sure to consult your healthcare provider before discontinuing Mounjaro or any other medication